A Comparison Between 12 Versus 20 Weeks of Trimethoprim-Sulfamethoxazole as Oral Eradication Treatment for Melioidosis (12vs20): An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial
Clicks: 260
ID: 111200
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
12.9
/100
43 views
43 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
AbstractBackground. Treatment of melioidosis comprises intravenous drugs for at least 10 days, followed by oral trimethoprim-sulfamethoxazole (TMP-SMX) for 12
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (17 words).
Try re-searching for a better abstract.
| Reference Key |
siriluckclinicala
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Anunnatsiri, Siriluck;Chaowagul, Wipada;Teparrukkul, Prapit;Chetchotisakd, Ploenchan;Tanwisaid, Kittisak;Khemla, Supphachoke;Narenpitak, Surapong;Pattarapongsin, Moragot;Kongsawasd, Wirod;Pisuttimarn, Pornrith;Thipmontree, Wilawan;Mootsikapun, Piroon;Chaisuksant, Seksan;Chierakul, Wirongrong;Day, Nicholas P J;Limmathurotsakul, Direk; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.